Health Catalyst, Inc.
HCAT
$3.80
-$0.185-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.88% | 3.60% | 4.15% | 5.23% | 5.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.88% | 3.60% | 4.15% | 5.23% | 5.24% |
| Cost of Revenue | 4.18% | 2.28% | 4.67% | 8.37% | 11.64% |
| Gross Profit | 5.72% | 5.17% | 3.55% | 1.75% | -1.50% |
| SG&A Expenses | -13.51% | -9.37% | -14.83% | -17.66% | -19.35% |
| Depreciation & Amortization | 3.53% | -1.88% | -4.85% | -8.93% | -12.36% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.48% | -5.02% | -5.95% | -5.53% | -4.74% |
| Operating Income | 37.44% | 34.34% | 35.40% | 33.05% | 28.59% |
| Income Before Tax | 31.31% | 41.28% | 35.72% | 41.43% | 29.34% |
| Income Tax Expenses | 8.75% | -6.46% | -154.78% | 4.34% | 160.61% |
| Earnings from Continuing Operations | 31.16% | 41.17% | 35.98% | 41.32% | 28.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.16% | 41.17% | 35.98% | 41.32% | 28.75% |
| EBIT | 37.44% | 34.34% | 35.40% | 33.05% | 28.59% |
| EBITDA | 61.57% | 52.35% | 50.16% | 43.48% | 34.39% |
| EPS Basic | 37.88% | 44.95% | 39.34% | 44.20% | 31.98% |
| Normalized Basic EPS | 29.85% | 32.16% | 39.97% | 42.26% | 38.85% |
| EPS Diluted | 37.88% | 44.95% | 39.34% | 44.20% | 31.98% |
| Normalized Diluted EPS | 29.85% | 32.16% | 39.97% | 42.26% | 38.85% |
| Average Basic Shares Outstanding | 9.58% | 6.68% | 5.90% | 5.37% | 4.95% |
| Average Diluted Shares Outstanding | 9.58% | 6.68% | 5.90% | 5.37% | 4.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |